B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice
Authors
Keywords
-
Journal
TRANSFUSION
Volume 57, Issue 11, Pages 2595-2608
Publisher
Wiley
Online
2017-08-24
DOI
10.1111/trf.14288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Red cell alloimmunisation in patients with different types of infections
- (2016) Dorothea Evers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization
- (2016) Abhinav Arneja et al. HAEMATOLOGICA
- Bridging channel dendritic cells induce immunity to transfused red blood cells
- (2016) Samuele Calabro et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization
- (2016) Abhinav Arneja et al. HAEMATOLOGICA
- The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice
- (2016) David R. Gibb et al. EBioMedicine
- Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization
- (2015) Alex B. Ryder et al. BRITISH JOURNAL OF HAEMATOLOGY
- Engineering antigen-specific immunological tolerance
- (2015) Stephan Kontos et al. CURRENT OPINION IN IMMUNOLOGY
- Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series
- (2015) Robert Sheppard Nickel et al. TRANSFUSION
- Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
- (2015) Alizée J. Grimm et al. Scientific Reports
- Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease
- (2014) Ross M. Fasano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival
- (2014) Marilyn J. Telen et al. TRANSFUSION
- Responder Individuality in Red Blood Cell Alloimmunization
- (2014) Günther F. Körmöczi et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models
- (2014) Alex B. Ryder et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Pathogenic potential of interferon αβ in acute influenza infection
- (2014) Sophia Davidson et al. Nature Communications
- Sifalimumab, a Human Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
- (2013) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
- (2013) E. B. Wilson et al. SCIENCE
- Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
- (2013) J. R. Teijaro et al. SCIENCE
- Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies
- (2013) Sean R. Stowell et al. TRANSFUSION
- High Risk of Transfusion-induced Alloimmunization of Patients with Inflammatory Bowel Disease
- (2012) Pavol Papay et al. AMERICAN JOURNAL OF MEDICINE
- Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
- (2012) K. Yazdanbakhsh et al. BLOOD
- Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
- (2012) Matthew M. Meredith et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells
- (2012) Nicole H. Smith et al. TRANSFUSION
- Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
- (2011) B. W. Higgs et al. ANNALS OF THE RHEUMATIC DISEASES
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic sclerosis and lupus: Points in an interferon-mediated continuum
- (2010) Shervin Assassi et al. ARTHRITIS AND RHEUMATISM
- ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo
- (2010) David R. Gibb et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus
- (2009) Yihong Yao et al. ARTHRITIS AND RHEUMATISM
- Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice
- (2009) W. Bao et al. BLOOD
- Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells
- (2009) I. Douagi et al. JOURNAL OF IMMUNOLOGY
- Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
- (2009) Mark H. Yazer et al. TRANSFUSION
- Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells
- (2008) Jeanne E. Hendrickson et al. TRANSFUSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started